Tag: Vuse

  • Vuse Named ‘Pacesetter’

    Vuse Named ‘Pacesetter’

    Photo: R.J. Reynolds Vapor Co.

    R.J. Reynolds Vapor Co.’s (RJRVC) Vuse Alto and Vuse Ciro e-cigarettes were named two of the Top-10 product pacesetters by Information Resources Inc. (IRI), a data and analytics research group that closely monitors the consumer package goods (CPG) industry.

    Each year top CPG brands are recognized as IRI New Product Pacesetters, a list highlighting innovation that are resonating most with consumers.

    “Today’s adult nicotine consumers are looking for unique products that fit their modern-day lives, and Vuse has built a portfolio of options that have consumer moments in mind,” said Leila Medeiros, U.S. head of the Vuse brand.

    “Our dynamic approach to developing vapor products, paired with our team’s unrivaled industry knowledge, global market scale and commitment to responsible marketing, means we can create brands that adult nicotine consumers prefer, and products that deliver unique, enjoyable and reliable experiences.”

    R.J. Reynolds has submitted several Vuse products to the U.S. Food and Drug Administration for marketing authorization.

  • Vuse,Vype Launch Vapor Subscription Service

    Vuse,Vype Launch Vapor Subscription Service

    vype

    Vuse and Vype, global e-cigarette brands, have launched a personalized subscription service for their adult consumers that allows ordering at the touch of a button. With a variety of plans to choose from, vapers can sign up for monthly deliveries that offer value, convenience and personalisation.

    In the United Kingdom, Vype has launched two monthly subscription services focusing on its award-winning pod mods the Vype ePen3 and Vype ePod. Vype ePen3 and Vype ePod won the e-cigarette category at 2019 and 2020 UK Product of the Year awards respectively.

    Each subscription plan includes a Vype ePen3 or Vype ePod every three months with a 25 percent saving on a three-month plan or a 33 percent saving on a six-month plan, both with no delivery charges. Each plan requires a minimum order of six packs per month.

    In the United States, Vuse continues to offer its popular Vuse Alto pod subscription service that includes a 10 percent discount on pods and free delivery.

  • Countermove: Altria Sues Reynolds Over Patent Infringement

    Countermove: Altria Sues Reynolds Over Patent Infringement

    Altria Group Inc.’s e-cigarette and smokeless tobacco divisions filed suit Thursday against competitor R.J. Reynolds Vapor Co. for patent infringement on e-cigarettes and associated products.

    Altria owns a 35 percent stake in e-cigarette industry leader Juul Labs Inc., a direct competitor of Reynolds’ Vuse brand of e-cigarettes.

    According to a lawsuit filed in the U.S. District Court for the Middle District of North Carolina, Reynolds Vapor, owned by Reynolds American Inc., violated nine patents held by Altria Client Services in producing its Vuse Vapor e-cigarette line, according to a story on Virginiabusiness.com. The suit contends that Reynolds’ Vuse brand of e-cigarettes — including the Vibe and Alto — uses heating technology, mouthpieces, batteries and liquid-filled pods covered by Altria’s patents for its Juul e-vapor products.

    Based in Winston-Salem, North Carolina, Reynolds American Inc. is owned by British American Tobacco plc, which is headquartered in London. “Reynolds Vapor has infringed on Altria’s intellectual property and we are seeking financial damages for each of these violations,” Altria Client Services spokesman George Parman said Thursday, according to the story.

    The suit comes weeks after Reynolds filed its own patent-infringement suit against Altria and Philip Morris International Inc. in Richmond’s federal court over its heat-not-burn cigarette line, Marlboro HeatSticks, a competitor of Reynolds’ Eclipse line.

    Altria seeks unspecified monetary compensation but asks for “treble damages” — in other words, triple the amount — for “defendant’s willful infringement” of the patents, as well as awards of compensation, supplemental damages after discovery cutoff and attorneys’ fees and expenses. The plaintiffs ask for a trial by jury. No hearing has been set.

     

  • Vuse to Sponsor U.S. Tour of The Fratellis

    Vuse to Sponsor U.S. Tour of The Fratellis

    The R.J. Reynolds Vapor Company (RJRVC) announce that the Vuse brand will be a headline sponsor for the U.S. portion of The Fratellis’ upcoming international concert tour. This Vuse sponsorship is part of a broader sponsorship deal between British American Tobacco (“BAT”), RJRVC’s ultimate parent Group, and The Fratellis. To celebrate this sponsorship, The Fratellis will offer an exclusive sneak peak of their new song, “Strangers in the Street,” via Vuse Vapor’s U.S. age-restricted Instagram channel.

    The Fratellis are a multi-platinum, multi-award-winning Scottish rock band from Glasgow, formed in 2005. The band consists of lead vocalist and guitarist Jon Fratelli, bassist and backing vocalist Barry Fratelli, and drummer and backing vocalist Mince Fratelli. The Fratellis have announced that their sixth studio album, titled Half Drunk Under a Full Moon, to be released on October 30, 2020, alongside a full UK and North American tour.

    “We’re pleased to be part of The Fratellis’ upcoming U.S. tour, and to bring exclusive music and inspirational experiences for adult nicotine consumers,” says Leila Meideros, U.S. Head of Vuse Vapor.

    To celebrate the announcement of this sponsorship, The Fratellis will release a new track, “Strangers in the Street,” featuring legendary U.S. soul singer P.P. Arnold. This new track will premiere on Vuse Vapor’s U.S. age-restricted Instagram channel on May 7. The Fratellis will also be releasing a video that will be available exclusively on Vuse Vapor’s U.S. Instagram channel through May 14.

    “This song is a unique passion project for us. We recorded separately due to the pandemic and edited together to share through Vuse’s Instagram,” says Jon Fratelli, “We’re glad we can still put out music despite the circumstances, and we’re thankful to Vuse for helping make it happen.”

    To provide support to the music community during these challenging times, Vuse Vapor is including a link for individuals to donate to MusiCares through the Spotify Covid-19 Relief Fund. The Fratellis will also be donating 100% of their share of the proceeds from sales to Covid-19 relief funds.

    “COVID-19 has left the music community devasted, leaving many musicians and creators without jobs and an uncertain future,” says Meideros “We are thrilled to support this effort with The Fratellis, and in addition, are proud to make a corporate donation to help the music community.”

    U.S. Tour dates will be announced later this year.

    NOTE: Vuse Vapor’s U.S. Instagram account (@vusevaporus) is restricted to age 21+ nicotine consumers.

  • RAI Files 2 New PMTAs for Vuse Products

    RAI Files 2 New PMTAs for Vuse Products

    Reynolds American Inc. (RAI) has submitted two new premarket tobacco product applications (PMTAs) to the U.S. Food and Drug Administration (FDA). RAI is seeking marketing orders for its Vuse Vibe and Vuse Ciro vapor products, which would allow these products to remain on the market after the FDA’s deadline for PMTAs for electronic nicotine-delivery systems.

    The applications include a range of scientific studies for Vuse Vibe and Vuse Ciro using well-known methodologies, including the comparative assessment of cigarettes and associated health risks. Though the PMTAs themselves are considered commercially proprietary and are thus confidential, the data and information submitted to the FDA include the results of product analyses, nonclinical health risk information and human health and population information, including the impact to both users and nonusers of tobacco products.

    According to RAI, the results of these studies demonstrate that the continued marketing of the Vuse Vibe and Vuse Ciro products is appropriate for the protection of the public health. The FDA s expected to extend the PMTA deadline to from May 12 to Sept. 9.

    “I am incredibly proud of our diverse team of scientists, researchers and regulatory experts, who have worked tirelessly together to complete these applications well ahead of the FDA’s May deadline for ENDS products,” noted Reynolds’ executive vice president and head of scientific and regulatory affairs, James Figlar.

    The PMTAs for Vuse Vibe and Vuse Ciro are the second and third complete grouped PMTA applications submitted by Reynolds to the FDA for review, following the initial PMTA applications for Vuse Solo submitted in October 2019.